In certain embodiments, this present disclosure provides nucleic acid
compounds, compositions, and methods for inhibiting Ephrin B2 or EphB4
expression. In certain embodiments, the present disclosure provides
methods and compositions for treating cancer or for treating
angiogenesis-associated diseases.
